- Home
- STRO vs SNCR Comparison
STRO vs SNCR Comparison
Compare STRO & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SNCR
- Stock Information
- Founded
- STRO 2003
- SNCR 2000
- Country
- STRO United States
- SNCR United States
- Employees
- STRO N/A
- SNCR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SNCR EDP Services
- Sector
- STRO Health Care
- SNCR Technology
- Exchange
- STRO Nasdaq
- SNCR Nasdaq
- Market Cap
- STRO 74.3M
- SNCR 70.9M
- IPO Year
- STRO 2018
- SNCR 2006
- Fundamental
- Price
- STRO $0.89
- SNCR $5.97
- Analyst Decision
- STRO Hold
- SNCR Strong Buy
- Analyst Count
- STRO 7
- SNCR 1
- Target Price
- STRO $1.97
- SNCR $13.00
- AVG Volume (30 Days)
- STRO 598.8K
- SNCR 64.3K
- Earning Date
- STRO 11-12-2025
- SNCR 11-11-2025
- Dividend Yield
- STRO N/A
- SNCR N/A
- EPS Growth
- STRO N/A
- SNCR N/A
- EPS
- STRO N/A
- SNCR N/A
- Revenue
- STRO $104,473,000.00
- SNCR $171,870,000.00
- Revenue This Year
- STRO $65.42
- SNCR $1.51
- Revenue Next Year
- STRO N/A
- SNCR $5.43
- P/E Ratio
- STRO N/A
- SNCR N/A
- Revenue Growth
- STRO N/A
- SNCR 2.54
- 52 Week Low
- STRO $0.52
- SNCR $5.25
- 52 Week High
- STRO $4.80
- SNCR $15.46
- Technical
- Relative Strength Index (RSI)
- STRO 48.52
- SNCR 46.83
- Support Level
- STRO $0.85
- SNCR $5.41
- Resistance Level
- STRO $1.01
- SNCR $5.89
- Average True Range (ATR)
- STRO 0.09
- SNCR 0.29
- MACD
- STRO -0.01
- SNCR 0.06
- Stochastic Oscillator
- STRO 16.57
- SNCR 73.11
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.